MedPath

XIGRIS (5MG/VIAL)

XIGRIS (5MG/VIAL)

Discontinued
DIN Number

02247129

Drug Class

Human

Market Date

Feb 20, 2003

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02247129
AIG Number0148944001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
B01AD10 DROTRECOGIN ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DROTRECOGIN ALFA (ACTIVATED)Active
Strength: 5 MG / VIAL
Monograph: DROTRECOGIN ALFA (ACTIVATED)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.